M
METiS Therapeutics
AI-driven platform for drug discovery and delivery
At a glance
- Founded
- 2017
- Headquarters
- Cambridge, United States
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tier
Latest news
Press, funding announcements and product moves mentioning METiS Therapeutics.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed6 investors entered at this stage
Series A5 investors entered at this stage
- CIChina Life Private Equity Investment
- HSHSG
- CIChina Life Insurance
5Y Capital- PGPicc Group
Series B and later6 investors entered at this stage
- PCPICC Capital
- CCCMB International Capital
CICC- MMMonolith Management
- MTMassachusetts Institute of Technology
- CIChina Taiping Insurance
Source: Dealroom Talent Intelligence.
Global footprint
across markets
Patents
9 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about METiS Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See METiS Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.




